Cargando…
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
BACKGROUND: Clinical trial transparency is important to participants, trialists, publishers, and regulators, and there have been recent major policy changes by the pharmaceutical industry regarding clinical study data sharing. However, it is unknown if these changes are enabling independent research...
Autores principales: | Hopkins, Ashley M., Rowland, Andrew, Sorich, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/ https://www.ncbi.nlm.nih.gov/pubmed/30261889 http://dx.doi.org/10.1186/s12916-018-1154-z |
Ejemplares similares
-
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
por: Modi, Natansh D., et al.
Publicado: (2022) -
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies
por: Modi, Natansh D., et al.
Publicado: (2023) -
Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016) -
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages
por: Hopkins, Ashley M., et al.
Publicado: (2023) -
Industry-Sponsored Research: Author's Reply
por: Sotelo, Julio
Publicado: (2006)